BUSINESS MODEL

Natco Pharma Q4 net profit rises 40%

In the crop health sciences (CHS) business, due to the poor crop season the stock returns were more than expected by Rs 25 crore and provisions on assets of CHS division amounted to about Rs 30 crore. “This was done due to non-utilization of certain assets used for manufacturing of agro intermediates,” the company informed the bourses.